✨ Your Portfolio is fetched and updated from zerodha.
Micro Hospitals
Market Cap
₹47 Cr.
P/E
20.65
About
Tejnaksh Healthcare Ltd. owns and operates a hospital under the brand name of the Institute of Urology. Its services include pediatric urology, adult urology (male and female), andrology and sexual dy… Read more
Tejnaksh Healthcare Ltd. owns and operates a hospital under the brand name of the Institute of… Read more
Low
21
52W Range
High
31
  • Tejnaksh Healthcare
  • Family Care Hospital
  • Global Longlife Hosp

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison
Corporate Actions
Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less
FAQs on Tejnaksh Healthcare Ltd. Business

Tejnaksh Healthcare Ltd. operates the Institute of Urology hospital in Mumbai, Maharashtra, offering a range of urology and nephrology services including pediatric and adult urology, andrology, sexual dysfunction, dialysis, and renal transplant.

Tejnaksh Healthcare major competitors are Family Care Hospital, Global Longlife Hosp, Fortis MalarHospital, Aashka Hospitals, KMC Speciality Hosp, Dr Agarwals Eye Hsp, Shalby.
Market Cap of Tejnaksh Healthcare is ₹47 Crs.
While the median market cap of its peers are ₹248 Crs.

Tejnaksh Healthcare seems to be less financially stable compared to its competitors.
Altman Z score of Tejnaksh Healthcare is 5.04 and is ranked 4 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Investor Presentation Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material